Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab

Abstract

Abstract We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.

Keywords

• Chronic urticaria
• Normocomplementaemic urticarial vasculitis
• Omalizumab
• Urticaria
• Urticarial vasculitis